University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 12 of 13
PROS Brief Smoking Cessation Counseling in Pediatric Practice to Reduce Secondhand Smoke Exposure of Young Children
NCT00135213
Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.
NCT00288808
A Study to Examine the Relationship Between Sleep Apnea and Cleft Lip/Palate
NCT00156442
Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT00309998
Safety and Efficacy of Laparoscopic Truncal Vagotomy for the Treatment of Obesity
NCT00285220
Emergency Pharmacist Safety Study
NCT00382434
Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
NCT00212316
Study of Antidepressants in Parkinson's Disease
NCT00086190
Treatment of Insomnia Secondary to Chronic Pain
NCT00127790
Randomized Trial for Botox Urinary Incontinence
NCT00178191
Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence
NCT00178282
Bortezomib in Treating Patients With Myelodysplastic Syndromes
NCT00262873
Erythema Toxicum Neonatorum in Newborns and the Development of Asthma
NCT00178152
Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT00262860
Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis
NCT00156520
Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
NCT00258271
Arthroscopic Anterior Cruciate Ligament Reconstruction: A Comparison of Three Catheter Placement Positions
NCT00178178
Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing
NCT00156533
The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia
NCT00124384
Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix
NCT00178269
PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients
NCT00178425
Effect of High Blood Pressure and Antihypertensive Treatment on Brain Functioning in Children
NCT00178490
Maintaining HIV Prevention Gains in Female Adolescents
NCT00161343
A Qualitative Study About Smoking Practices
NCT00156481
Radiation Dosimetry in Teeth
NCT00178347
Sleep Architecture and Chemotherapy-Related Fatigue
NCT00178204
Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin
NCT01785615
Pilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and Adolescents
NCT00222963
Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer
NCT00178386
Workplace-Sponsored Program to Reduce Obesity
NCT00123513
Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence
NCT00178685
Cognitive Behavioral Therapy for the Treatment of Depression-Related Insomnia
NCT00255905
Effects of Music Therapy on Huntington's Disease
NCT00178360
Vitamin E and Male Infertility
NCT00178516
Attitudes About Smoking: A Telephone Survey
NCT00156494
Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer
NCT00178373
Music Therapy for Patients Being Weaned From Mechanical Ventilation
NCT00178139
Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
NCT00258297
Evaluation of a School-Based Training Program for Suicide Prevention
NCT00118443
GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer
NCT00262808
Lexapro in the Treatment of Patients With Postpartum Depression
NCT00277108
NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485
NCT00076492
MMR and Varicella Vaccine in Premature Infants
NCT00156559
Diet and Behavior in Young Children With Autism
NCT00090428
Interventions for Depressed Low Income Mothers and Their Infants
NCT00105573
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
NCT00255684
CT Scan Using IV Contrast Alone for Pediatric Appendicitis
NCT00716703
Office-Based Asthma Screening Intervention
NCT00156468
Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage
NCT05098236
Nesiritide and Vo2 Max in Heart Failure Patients
NCT00240084
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Rochester pipeline card: 636 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.